Kannaway made its debut on the European cannabigerol (CBG) market on Thursday by its parent company Medical Marijuana Inc. MJNA.
The move comes on the heels of Kannnaway's entering into the U.S. cannabinol market with the introduction of two new CBN isolate products.
Each bottle of Kannaway's newly released product contains 200 milligrams of CBD and 500 milligrams of CBG coming from European organic hemp.
Products are certified via the company's Triple Lab Testing process, the San Diego company confirmed.
"As CBD continues to grow in acceptance around the world, the market for cannabinoids like CBG also expands," noted Kannaway CEO Blake Schroeder. "Our company intends to continue to be at the forefront of expanding access to cannabinoids just as we have been with CBD."
Meantime, earlier this year, Kannaway tapped NHL and network marketing veteran Mike Hartman to its Sports Team to endorse CBD, and also Carolyn Dielmann Connolly as its new brand ambassador.
In January, Kannaway was named the Most Popular Cannabidiol (CBD) MLM Company in HealthMJ's new 2020 list.
Courtesy image
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
